 Epsilon, EB, and diphenyl disilennide, PHA2, have been shown to be effective in inhibiting the replication of the SARS-CoV-2 virus in vitro. In addition, these compounds did not show any toxic effects on human peripheral blood mononuclear cells, PBMCs, suggesting they could potentially be used as a treatment option for people infected with the virus. This article was authored by Guilherme Wildner, Amanda Risen Tucci, Alessandro de Sousa Prestes, and others.